Growth Metrics

Welsis (WLSS) Return on Sales (2022 - 2024)

Welsis' quarterly Return on Sales came in at 0.32% in Q3 2024, down 32.0% year-on-year from 0.47% in Q4 2023, and down 1648.3% quarter-over-quarter from 0.02% in Q2 2024.

Welsis has reported Return on Sales for 3 years, with the latest figure at 0.32% in Q3 2024.

  • For the quarter ending Q3 2024, Return on Sales fell 32.0% year-over-year to 0.32%; the trailing twelve-month figure through Sep 2024 stood at 0.32% (down 31.0% YoY), and the FY2024 full-year result was 0.32%, down 31.0% from the prior year.
  • Return on Sales for Q3 2024 stood at 0.32%, down from 0.02% in the prior quarter.
  • The five-year high for Return on Sales was 0.0% in Q3 2023, with the low at 0.32% in Q3 2024.
  • Average Return on Sales over 3 years is 0.08%, with a median of 0.02% recorded in 2022.
  • Peak annual rise in Return on Sales reached 16 bps in 2024, while the deepest fall reached 32 bps in 2024.
  • Tracing WLSS's Return on Sales over 3 years: stood at 0.03% in 2022, then tumbled by 152 bps to 0.07% in 2023, then slumped by 385 bps to 0.32% in 2024.
  • The last three Return on Sales figures came in at 0.32% (Q3 2024), 0.02% (Q2 2024), and 0.01% (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 0.00%
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 0.00%
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 0.00%
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 0.00%
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 0.00%
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 0.00%
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 0.00%
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 0.00%
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 0.00%
10 Welsis - - - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2024 -0.32%
Jun 30, 2024 -0.02%
Mar 31, 2024 -0.01%
Dec 31, 2023 -0.07%
Sep 30, 2023 0.00%
Jun 30, 2023 -0.01%
Mar 31, 2023 -0.18%
Dec 31, 2022 -0.03%